Metabolomics is one of the “omics” technologies and is a comprehensive analysis of small molecule metabolites. The metabolomics is located at the downstream end of “omics” research; therefore, this research platform is most closely related to phenotype among other “omics” research. Recently, we compared the differences of metabolite profiling between patients with ossification of the posterior longitudinal ligament (OPLL) and control subjects for the first time and detected 259 metabolites. Among the 259 metabolites, some metabolites were significantly larger in OPLL group, even in analyses excluding patients with diabetes mellitus and hyperlipidemia. Although this research field is still in development, these results of the present study could lead to new insights into clarifying the molecular pathomechanisms of OPLL.
KeywordsMetabolomics Metabolite Comprehensive analysis Ossification of the posterior longitudinal ligament Genomics Transcriptomics Proteomics
- 2.Nakajima M, Takahashi A, Tsuji T, Karasugi T, Baba H, Uchida K, Kawabata S, Okawa A, Shindo S, Takeuchi K, Taniguchi Y, Maeda S, Kashii M, Seichi A, Nakajima H, Kawaguchi Y, Fujibayashi S, Takahata M, Tanaka T, Watanabe K, Kida K, Kanchiku T, Ito Z, Mori K, Kaito T, Kobayashi S, Yamada K, Takahashi M, Chiba K, Matsumoto M, Furukawa K, Kubo M, Toyama Y, Genetic Study Group of Investigation Committee on Ossification of the Spinal Ligaments, Ikegawa S. A genome-wide association study identifies susceptibility loci for ossification of the posterior longitudinal ligament of the spine. Nat Genet. 2014;46(9):1012–6.PubMedGoogle Scholar
- 3.Shingyouchi Y, Nagahama A, Niida M. Ligamentous ossification of the cervical spine in the late middle-aged Japanese men. Its relation to body mass index and glucose metabolism. Spine (Phila Pa 1976). 1996;21(21):2474–8.Google Scholar
- 4.Wang PN, Chen SS, Liu HC, Fuh JL, Kuo BI, Wang SJ. Ossification of the posterior longitudinal ligament of the spine. A case-control risk factor study. Spine (Phila Pa 1976). 1999;24(2):142–4; discussion 145.Google Scholar
- 6.Newgard CB. Metabolomics and metabolic diseases: where do we stand? Cell Metab. 2017;25(1):43–56.Google Scholar
- 12.Ikeda Y, Nakajima A, Aiba A, Koda M, Okawa A, Takahashi K, Yamazaki M. Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament. Eur Spine J. 2011;20(9):1450–8.PubMedPubMedCentralGoogle Scholar
- 17.Ahn SH, Park SY, Baek JE, Lee SY, Baek WY, Lee SY, Lee YS, Yoo HJ, Kim H, Lee SH, Im DS, Lee SK, Kim BJ, Koh JM. Free fatty acid receptor 4 (GPR120) stimulates bone formation and suppresses bone resorption in the presence of elevated n-3 fatty acid levels. Endocrinology. 2016;157(7):2621–35.PubMedGoogle Scholar